ctrl K

Verve Therapeutics Inc. (VERV)

NASDAQ: VERV · Real-Time Price · USD

5.50

-0.17 (-3.00%)

At close: May 01, 2025, 3:59 PM

5.62

2.18%

Pre-market: May 02, 2025, 09:18 AM EDT

Verve Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	32.33M	11.76M	1.94M	n/a	n/a	n/a
Cost of Revenue	6.75M	5.46M	6.71M	3.38M	1.33M	106K
Gross Profit	25.58M	6.3M	-4.77M	-3.38M	-1.33M	-106K
Operating Income	-228.66M	-223.12M	-165.69M	-87.07M	-40.63M	-13.64M
Interest Income	n/a	n/a	6.87M	142K	162K	278K
Pretax Income	-198.36M	-199.79M	-157.33M	-120.31M	-45.7M	-19.3M
Net Income	-198.71M	-200.07M	-157.39M	-118.64M	-45.54M	-19.02M
Selling & General & Admin	56.65M	49.94M	37.53M	18.86M	5.26M	2.5M
Research & Development	204.35M	184.95M	130.09M	68.2M	35.37M	11.14M
Other Expenses	n/a	n/a	1.49M	-33.39M	-5.24M	-5.93M
Operating Expenses	260.99M	234.88M	167.63M	87.07M	40.63M	13.64M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	260.99M	234.88M	167.63M	87.07M	40.63M	13.64M
Income Tax Expense	349K	275K	53K	-1.68M	-162K	-278K
Shares Outstanding (Basic)	84.72M	64.18M	54.02M	48.51M	48.22M	48.22M
Shares Outstanding (Diluted)	84.72M	64.18M	54.02M	48.51M	48.22M	48.22M
EPS (Basic)	-2.36	-3.12	-2.91	-2.45	-0.94	-0.39
EPS (Diluted)	-2.35	-3.12	-2.91	-2.45	-0.94	-0.39
EBITDA	-228.66M	-217.67M	-162.88M	-85.53M	-39.3M	-13.54M
EBIT	-228.66M	-223.12M	-165.69M	-120.31M	-40.63M	-13.64M
Depreciation & Amortization	n/a	5.46M	6.71M	3.38M	1.33M	106K